Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants

J Biol Chem. 1990 Nov 25;265(33):20293-301.

Abstract

Three chimeric mutants of plasminogen activator inhibitor 1 (PAI-1) have been constructed where the strained loop of wild type PAI-1 (wtPAI-1) has been replaced with a 19-amino acid region from either plasminogen activator inhibitor 2 (PAI-2), antithrombin III, or with an artificial serine protease inhibitor superfamily consensus strained loop. The inhibitors were expressed in Escherichia coli, and the purified proteins had specific activities toward urokinase-type plasminogen activator (uPA) or the single- and two-chain forms of tissue type plasminogen activator (tPA) that were similar to wtPAI-1. Experiments suggest that the strained loop of PAI-1 is not responsible for the transition between the latent and the active conformations or for binding to vitronectin. Second-order rate constants for the interactions with uPA and single- or two-chain tPA were similar to those of wtPAI-1. Values range from a low of 1.8 x 10(5) M-1 s-1 for the interaction of the PAI-2 chimera with single-chain tPA to a high value of 1.6 x 10(7) M-1 s-1 for the consensus mutant with two-chain tPA. This former value is 200 times higher than the reported rate constant for the interaction between PAI-2 and single-chain tPA, suggesting that structures outside of the strained loop are responsible for the major differences in specificity between PAI-1 and PAI-2.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • Circular Dichroism
  • Cloning, Molecular
  • Escherichia coli / genetics
  • Glycoproteins / metabolism
  • Humans
  • Kinetics
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed*
  • Oligonucleotide Probes
  • Plasmids
  • Plasminogen Inactivators / metabolism*
  • Protein Conformation
  • Restriction Mapping
  • Sequence Homology, Nucleic Acid
  • Vitronectin

Substances

  • Glycoproteins
  • Oligonucleotide Probes
  • Plasminogen Inactivators
  • Vitronectin